Literature DB >> 17652791

A retroviral vector for siRNA expression in mammalian cells.

Gro Leite Størvold1, Elisabet Gjernes, Hanne Arenberg Askautrud, Anne-Lise Børresen-Dale, Charles M Perou, Eirik Frengen.   

Abstract

Utilization of RNA interference (RNAi) for knockdown of gene expression has become a standard tool for the study of gene function. Short hairpin RNAs (shRNAs) expressed from RNA polymerase III promoters are widely used to achieve stable knockdown of gene expression by RNAi. We have constructed a retroviralbased shRNA expression vector, pSiRPG, as a tool for shRNA-based functional genomic studies. This vector is based on a widely used shRNA expression system and was modified to harbor an enhanced green fluorescent protein (EGFP) and a puromycin selection marker. The functionality of the elements in the pSiRPG vector was validated. The H1(TetO2) promoter in the vector facilitates doxycycline-inducible shRNA expression, which was demonstrated in cells expressing the Tet repressor (TetR). However, we also demonstrated limited efficiency of the inhibition of shRNA expression in an uninduced TetR-expressing cell line. This observation strongly indicates that the H1(TetO2) promoter, which is used in a wide range of vectors, is not optimal for tightly regulated shRNA expression. Stable repression of the NDRG1 protein level was observed when introducing pSiRPG constructs expressing shRNAs targeting NDRG1 into two mammary epithelial cell lines by retroviral delivery. This vector should therefore facilitate functional studies in breast cell lines that are hard to transfect with conventional plasmid-based methods.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652791     DOI: 10.1007/bf02686013

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  23 in total

1.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

2.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Authors:  Guangchao Sui; Christina Soohoo; El Bachir Affar; Frédérique Gay; Yujiang Shi; William C Forrester; Yang Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  Gene silencing using micro-RNA designed hairpins.

Authors:  Michael T McManus; Christian P Petersen; Brian B Haines; Jianzhu Chen; Phillip A Sharp
Journal:  RNA       Date:  2002-06       Impact factor: 4.942

Review 4.  Mechanisms of gene silencing by double-stranded RNA.

Authors:  Gunter Meister; Thomas Tuschl
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

5.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

6.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

7.  Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector.

Authors:  Marc van de Wetering; Irma Oving; Vanesa Muncan; Menno Tjon Pon Fong; Helen Brantjes; Dik van Leenen; Frank C P Holstege; Thijn R Brummelkamp; Reuven Agami; Hans Clevers
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

8.  Establishment of conditional vectors for hairpin siRNA knockdowns.

Authors:  Shiro Matsukura; Peter A Jones; Daiya Takai
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

9.  Cell-type-specific responses to chemotherapeutics in breast cancer.

Authors:  Melissa A Troester; Katherine A Hoadley; Therese Sørlie; Brittney-Shea Herbert; Anne-Lise Børresen-Dale; Per Eystein Lønning; Jerry W Shay; William K Kaufmann; Charles M Perou
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

10.  NDRG1 is necessary for p53-dependent apoptosis.

Authors:  Susanne Stein; Emily K Thomas; Birger Herzog; Matthew D Westfall; Jonathan V Rocheleau; Roger S Jackson; Mai Wang; Peng Liang
Journal:  J Biol Chem       Date:  2004-09-17       Impact factor: 5.157

View more
  5 in total

1.  shRNA expression constructs designed directly from siRNA oligonucleotide sequences.

Authors:  Tuva Barøy; Kirsten Sørensen; Mona Mari Lindeberg; Eirik Frengen
Journal:  Mol Biotechnol       Date:  2010-06       Impact factor: 2.695

2.  Inhibition of JNK1 expression decreases migration and invasion of mouse hepatocellular carcinoma cell line in vitro.

Authors:  Yu Hong Zhang; Shao Qing Wang; Cheng Rong Sun; Mei Wang; Bo Wang; Jian Wu Tang
Journal:  Med Oncol       Date:  2010-05-20       Impact factor: 3.064

3.  Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility.

Authors:  Benedicte Stavik; Grethe Skretting; Hans-Christian Aasheim; Mari Tinholt; Lillian Zernichow; Marit Sletten; Per Morten Sandset; Nina Iversen
Journal:  BMC Cancer       Date:  2011-08-17       Impact factor: 4.430

4.  Construction and Evaluation of Short Hairpin RNAs for Knockdown of Metadherin mRNA.

Authors:  Farahnaz Zare; Sedigheh Sharifzadeh; Abbas Behzad-Behbahani; Gholamreza Rafiei Dehbidi; Zahra Yousefi; Reza Ranjbaran; Noorossadat Seyyedi
Journal:  Avicenna J Med Biotechnol       Date:  2021 Oct-Dec

5.  Global gene expression analysis reveals a link between NDRG1 and vesicle transport.

Authors:  Hanne A Askautrud; Elisabet Gjernes; Gjermund Gunnes; Marit Sletten; Douglas T Ross; Anne Lise Børresen-Dale; Nina Iversen; Michael A Tranulis; Eirik Frengen
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.